4. ORGANIZATION-PROFILE AT STATE LEVEL STATE TUBERCULOSIS OFFICE - STATE TUBERCULOSIS OFFICER STATE TUBERCULOSIS TRAINING & DEMONSTRATION CENTRE - DIRECTOR DISTRICT TUBERCULOSIS CENTRE (DTC) - DISTRICT TUBERCULOSIS OFFICER TUBERCULOSIS UNIT - MEDICAL OFFICER - SENIOR TREATMENT SUPERVISOR(STS) - SENIOR TB LAB SUPERVISOR(STLS) MICROSCOPY CENTRES AND TREATMENT CENTRES DOTS PROVIDERS
5. LABORATORY NETWORK CENTRAL TB DIVISION NATIONAL REFERENCE LAB STATE TB CELL INTERMEDIATE REFERENCE LAB DISTRICT TB CENTRE TU TU TU DMC II DMC I DMC III NATIONAL LEVEL STATE LEVEL DISTRICT LEVEL (SPUTUM MICROSCOPY EQA) (SUPERVISION) (FEEDBACK)
14. DRUG RESISTANCE SURVEILLANCE AIM TO DETERMINE THE PREVALENCE OF ANTI-MYCOBACTERIAL DRUG RESISTANCE AMONG -NEW CASE -TREATED CASE PLANS STATE WIDE DRS SURVEYS ICMR SURVEYS BY 2010, A NETWORK OF 24 STATE-LEVEL CULTURE AND DRUG SENSITIVITY TESTING LABORATORIES
15. DOTS-PLUS STRATEGY CURRENTLY UNDER DEVELOPMENT BY WHO FOR THE MANAGEMENT OF MDR-TB CASES GOAL TO PREVENT FURTHER DEVELOPMENT OF MDR-TB PRE-REQUISITE AN EFFECTIVE DOTS BASED TB CONTROL PROGRAM ORGANISATION DESIGNATED RNTCP DOTS-PLUS SITES ATLEAST 1 IN EACH STATE WITH READY ACCESS TO RNTCP ACCREDITED CULTURE AND DRUG SUSCEPTIBILITY TESTING(DST) LABORATORY
16.
17.
18.
19.
20.
21. STOP TB STRATEGY VISION A WORLD FREE OF TB GOAL TO DRAMATICALLY REDUCE THE GLOBAL BURDEN OF TB BY 2015 IN LINE WITH THE MILLENNIUM DEVELOPMENT GOALS AND THE STOP TB PARTNERSHIP TARGETS